Search the Newsreel

Stocks To Watch Today: Vodafone Idea, Zee Entertainment, Gland Pharma, Wipro, Bata India, MRF, RVNL, BSE & More

Midea Real Estate Holding Limited Reports Earnings Results for the Half Year Ended June 30, 2026

IdeaForge Technology Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Vodafone Idea Q1: Revenue rises 6% YoY to ₹11,689 crore; ARPU jumps 10.2% to ₹195 — key highlights

Stocks to Watch for August 11: Wipro, Vodafone Idea, Bharat Electronics, Bosch and more

Vodafone Idea Q1 Results: Loss narrows to Rs 3,754 crore; revenue rises 6% YoY

Midea Real Estate Declares Interim Dividend for First Half of 2026

Midea Real Estate Margins Improve as Profit Slips, Dividend Held in Challenging Market

Midea Real Estate (03990) released its interim results, reporting a profit attributable to shareholders of RMB 255 million, a 16.65% year-on-year decrease.

How Investors Are Reacting To IDEAYA Biosciences (IDYA) Q2 Losses And IDE892 Trial Expansion

IDEAYA Biosciences reported Q2 2026 results with $8.86 million in revenue and a widened net loss of $112.45 million, or $1.22 per share. Despite the losses, the company advanced IDE892 into Part 2 monotherapy expansion for MTAP-deleted solid tumors, which is a positive development …

AMTD IDEA Group (AMTD) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for AMTD IDEA Group (AMTD), focusing on future EPS and revenue growth estimates. It includes a snapshot of the company's current stock performance, market capitalization, and P/E TTM ratio. The forecast section lists EPS, Revenue, Net Profit, and …

Vodafone Idea Q1 Results Today: Time, Earnings Call, What To Watch, Share Price Performance

Vodafone Idea Q1 results today: Key expectations, share price targets ahead of earnings

Q1 results 2026: Vodafone Idea to Bharat Forge among companies to declare Q1 results today; full list here

AMTD IDEA Warned by NYSE Over Sub-US$1 ADS Price, Faces Six-Month Cure Period

AMTD IDEA Group (AMTD) has been notified by the NYSE that its American depositary shares (ADS) have fallen below the minimum US$1.00 average closing price requirement, leading to a six-month cure period to regain compliance. The company is actively repurchasing ADSs to support trading …

LifeSci Capital Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $58

LifeSci Capital has reiterated its Buy rating for IDEAYA Biosciences (IDYA.US) and maintained its target price at $58. This indicates a continued positive outlook from the firm regarding the company's stock performance and potential.

Q1 results 2026: Vodafone Idea to RVNL among companies to declare Q1 results next week; check full list here

Q1 Results Tracker: Tata Motors, Vodafone Idea among 2,045 companies set to announce earnings this week

AMTD IDEA faces NYSE delisting risk after ADS p...

AMTD IDEA Group has received a delisting notice from the NYSE because its American depositary shares (ADS) traded below $1 for 30 consecutive days. The company has six months to regain compliance by raising its ADS price above $1. AMTD IDEA plans to monitor …

Ideal Power Inc (IPWR) Stock News Today

This page provides current stock news for Ideal Power Inc (IPWR), including its stock performance and market capitalization. As of the closing bell on August 7th, the stock was trading at $4.520, up 5.85%, with an after-hours price of $4.270 on August 10th. The …

Ideal Power (IPWR.US) will release its earnings report before market open on August 13.

Ideal Power (IPWR.US) is scheduled to release its earnings report before the market opens on August 13. This announcement provides investors with the date of the upcoming financial disclosure.

AMTD IDEA Group (AMTD) Stock News Today

This page provides the latest news for AMTD IDEA Group (AMTD) stock on TradingKey, including its current stock price and key financial metrics. The platform indicates that more news will be coming soon for the company.

AMTD IDEA has six months to meet NYSE's $1 ADS price rule

AMTD IDEA Group (NYSE: AMTD) has received a notice from the NYSE because its American Depositary Shares (ADSs) have traded below $1.00 for 30 consecutive trading days, violating Section 802.01C. The company has a six-month "Cure Period" until February 7, 2027, to regain compliance …

AMTD IDEA Group (NYSE: AMTD) faces NYSE price-compliance deadline

AMTD IDEA Group has received a notice from the NYSE indicating non-compliance due to its American depositary shares (ADSs) trading below US$1.00 for 30 consecutive days. The company has a six-month "Cure Period" to regain compliance by achieving a closing price and a 30-day …

AMTD IDEA's Receipt of NYSE Letter Regarding ADS Trading Price's Below Compliance Standards

AMTD IDEA Group has received a letter from the NYSE notifying the company that its American depositary shares (ADSs) are trading below compliance standards, with an average closing price of less than US$1.00 for 30 consecutive trading days. The company has six months to …

IDEAYA Biosciences (IDYA) Stock Could Be Fully Valued After Trial Progress

IDEAYA Biosciences (IDYA) stock has delivered a 61.0% return over five years, but its current P/S ratio of 14.9x suggests it might be overvalued compared to the biotech industry average and a fair P/S of 4.3x implied by the model. While progress in its …

IPWR Q2'26 Earnings: revenue estimate is 0 USD

Ideal Power Inc. (IPWR) is scheduled to release its Q2'26 earnings on August 13th, before market open. The company's revenue estimate for the quarter is $0, with an anticipated EPS of -$0.23. The article also provides a table summarizing past and estimated revenue and …

Vodafone Idea, Motherson, Allcargo, PC Jeweller in Focus

IDEAYA Biosciences, Inc. (IDYA) stock price, news, quote and history

This article provides a detailed financial overview of IDEAYA Biosciences, Inc. (IDYA), including its current stock price, historical data, and analyst ratings. It highlights the company's focus on developing targeted therapeutics for oncology and lists its key drug candidates and strategic alliances. The report …

Vodafone Idea Q1 Results: Earnings call scheduled for Aug 11

Ideal Power (IPWR) Projected to Release Earnings on Thursday

Ideal Power (NASDAQ:IPWR) is anticipated to announce its Q2 2026 earnings before market open on Thursday, August 13th, with analysts forecasting a loss of $0.23 per share and revenue of $0.10 million. The company previously missed its Q1 estimates, reporting a loss of $0.33 …

The Bull Case For IDEAYA Biosciences (IDYA) Could Change Following Wider Loss And New Roche Partnership

IDEAYA Biosciences recently reported a wider Q2 2026 net loss of US$112.45 million, or US$1.22 per share, and an overall wider six-month loss compared to the previous year. Despite this, the company is advancing its precision oncology pipeline, initiating a monotherapy expansion for IDE892 …

IDEAYA Biosciences (NASDAQ:IDYA) Given New $59.00 Price Target at Truist Financial

IDEAYA Biosciences 2Q 2026: Revenue $8.86M, EPS $(1.22) — 10-Q Summary

IDEAYA Biosciences reported its second-quarter 2026 results, showing collaboration revenue of $8.86 million and a net loss of $(112.45) million, or $(1.22) diluted EPS, due to increased R&D and commercial preparation. The company highlighted positive Phase 2/3 clinical trial results for darovasertib, with an …

IDEAYA BIOSCIENCES, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $31 FROM $37

Leerink Partners has decreased its target price for IDEAYA Biosciences, Inc. (IDYA.O) from $37 to $31. This adjustment was reported by Reuters on August 5, 2026, at 12:21 PM. The article provides this key financial action without further elaborating on the reasons behind the …

IDEAYA Biosciences (IDYA) Stock Faces Loss Pressure Despite Revenue Traction

IDEAYA Biosciences (IDYA) stock saw a modest increase after its Q2 2026 earnings report, which highlighted significant revenue growth but also widening net losses. While the company achieved substantial revenue traction and secured new funding, its increasing cash burn and lack of a clear …